Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small cell lung cancer (NSCLC) with poor prognosis. The skipping mutation in exon 14 of MET, an oncogenic driver of NSCLC, occurs more frequently in PSC than other subtypes. Treatment options for patients with PSC include targeted therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Ling, Wei, Xiaoying, Zhang, Zixiang, Heng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801627/
https://www.ncbi.nlm.nih.gov/pubmed/35110965
http://dx.doi.org/10.1177/11795549211067185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801627/
https://www.ncbi.nlm.nih.gov/pubmed/35110965
http://dx.doi.org/10.1177/11795549211067185

Ejemplares similares